Synthesis and Biological Evaluation of Novel Laropiprant Derivatives As Potential Anti-Allergic Agents

Haiping Zhou,Qihua Zhu,Zongjie Gan,Guangping Dong,Yungen Xu

DOI: https://doi.org/10.1007/s00044-015-1431-8

2015-01-01

Medicinal Chemistry Research

Abstract:DP antagonists are claimed to be useful in the treatment of allergic disorders. Laropiprant is a potent and selective DP antagonist to reduce the allergic disorders, especially niacin-induced flushing. In our study, a series of novel laropiprant derivatives (I-1 – I-18) were synthesized and characterized by IR, 1 H-NMR, 13 C-NMR and HRMS spectrum. The potency of these compounds was evaluated in a murine model of niacin-induced flushing. The results indicated that most compounds exhibited faster-acting effect of suppressing vasodilation than laropiprant. Among them, I-1 , I-2 , I-3 , I-9 , I-13 , I-15 and I-16 exhibited substantial flushing inhibitory effect. Especially, I-1 and I-2 showed higher potency than laropiprant and would be valuable for further investigation.